Explore ›
Finding
Finding
null
Donor bone marrow infusion did not significantly improve rejection prevention when added to the belatacept-sirolimus regimen, with all three episodes of subclinical rejection occurring in patients who did not receive marrow, though this difference was not statistically significant.
| Effect size | P=0.22 (Fisher's exact test) |
| Comparator | Belatacept-sirolimus regimen without donor bone marrow infusion (randomized 1:1) |
| Effect summary | null; P=0.22 (Fisher's exact test) |
Connected entities
Interventions
Conditions
Outcomes
Source
PMC4642731
Renal Transplantation Using Belatacept Without Maintenance Steroids or Calcineurin Inhibitors